|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
ATE157012T1
(de)
|
1989-11-03 |
1997-09-15 |
Univ Vanderbilt |
Verfahren zur in vivo-verabreichung von funktionsfähigen fremden genen
|
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
US5204253A
(en)
|
1990-05-29 |
1993-04-20 |
E. I. Du Pont De Nemours And Company |
Method and apparatus for introducing biological substances into living cells
|
|
IL105554A
(en)
*
|
1992-05-05 |
1999-08-17 |
Univ Leiden |
Peptides of human papillomavirus for use in preparations elicit a human T cell response
|
|
EP0646178A1
(en)
|
1992-06-04 |
1995-04-05 |
The Regents Of The University Of California |
expression cassette with regularoty regions functional in the mammmlian host
|
|
AU4998993A
(en)
|
1992-08-07 |
1994-03-03 |
Epimmune, Inc. |
Hla binding peptides and their uses
|
|
US9340577B2
(en)
|
1992-08-07 |
2016-05-17 |
Epimmune Inc. |
HLA binding motifs and peptides and their uses
|
|
WO2001000225A1
(en)
|
1999-06-29 |
2001-01-04 |
Epimmune Inc. |
Hla binding peptides and their uses
|
|
CN1118572A
(zh)
|
1993-03-05 |
1996-03-13 |
萨依特尔有限公司 |
Hla-a2.1组合肽及其用途
|
|
AU698962B2
(en)
|
1993-09-14 |
1998-11-12 |
Epimmune, Inc. |
Alteration of immune response using pan DR-binding peptides
|
|
US6071890A
(en)
|
1994-12-09 |
2000-06-06 |
Genzyme Corporation |
Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
|
|
US5849589A
(en)
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
|
FR2753627B1
(fr)
|
1996-09-20 |
2003-02-21 |
Galderma Rech Dermatologique |
Utilisation des inhibiteurs de l'activite de l'acide retinoique pour favoriser la cicatrisation
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
NO309798B1
(no)
|
1999-04-30 |
2001-04-02 |
Targovax As |
Peptidblanding, samt farmasoytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
|
|
EP2100620A1
(en)
*
|
1999-09-16 |
2009-09-16 |
Eisai Corporation of North America |
Nucleic acids encoding polyepitope polypeptides
|
|
US7026443B1
(en)
*
|
1999-12-10 |
2006-04-11 |
Epimmune Inc. |
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
|
|
CA2397998A1
(en)
|
2000-01-28 |
2001-08-02 |
Statens Serum Institut |
Hiv peptides and nucleic acids encoding them for diagnosis and control of hiv infection
|
|
CA2343602A1
(en)
|
2000-04-18 |
2001-10-18 |
Genset |
Est's and encoded human proteins
|
|
DK1296711T3
(da)
*
|
2000-06-26 |
2006-08-28 |
Stressgen Biotechnologies Corp |
HPV-E7 til behandling af humant papillomavirus
|
|
DE10037759A1
(de)
|
2000-08-03 |
2002-07-04 |
Gruenenthal Gmbh |
Screeningverfahren
|
|
EP1911461B1
(en)
*
|
2000-10-19 |
2011-12-07 |
Epimmune Inc. |
HLA class I and II binding peptides and their uses
|
|
US20040029114A1
(en)
|
2001-01-24 |
2004-02-12 |
Eos Technology, Inc. |
Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
|
|
WO2003004989A2
(en)
|
2001-06-21 |
2003-01-16 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
|
|
US20040076955A1
(en)
|
2001-07-03 |
2004-04-22 |
Eos Biotechnology, Inc. |
Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
|
|
EP1338606A1
(en)
*
|
2002-02-22 |
2003-08-27 |
Magnus Von Knebel Doeberitz |
Nucleic Acid encoding an HERV-H polypeptide for diagnosing colorectal cancer
|
|
CA2483106A1
(en)
|
2002-04-24 |
2003-11-06 |
Ginkgo Biomedical Research Institute Co., Ltd. |
Decoys for treating and/or preventing th2 cytokine-related allergic diseases, gata3 mutant proteins and, pharmaceutical compositions comprising the decoys and the proteins
|
|
CA2484941A1
(en)
|
2002-07-24 |
2004-02-05 |
Intercell Ag |
Antigens encoded by alternative reading frame from pathogenic viruses
|
|
DE60332377D1
(de)
*
|
2002-10-21 |
2010-06-10 |
Eisai Inc |
Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden
|
|
JP4647606B2
(ja)
*
|
2003-09-05 |
2011-03-09 |
ジェネンコー・インターナショナル・インク |
Ｈｐｖｃｄ８＋ｔ細胞エピトープ
|
|
US8673634B2
(en)
|
2003-11-13 |
2014-03-18 |
Massachusetts Eye & Ear Infirmary |
Method for the treatment of hearing loss
|
|
GB0413688D0
(en)
|
2004-06-18 |
2004-07-21 |
Novartis Forschungsstiftung |
Analysis of methylated nucleic acid
|
|
EP1827385B1
(en)
|
2004-11-23 |
2013-03-27 |
Adamas Pharmaceuticals, Inc. |
Pharmaceutical composition comprising memantine in an extended dosage release form for use in the treatment of dementias
|
|
US8252893B2
(en)
*
|
2005-01-31 |
2012-08-28 |
Board Of Trustees Of The University Of Arkansas |
CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
|
|
CN1299769C
(zh)
|
2005-01-31 |
2007-02-14 |
中国医学科学院肿瘤医院肿瘤研究所 |
人乳头瘤病毒和热休克蛋白重组蛋白疫苗及其用途
|
|
RU2494107C2
(ru)
|
2005-05-09 |
2013-09-27 |
Оно Фармасьютикал Ко., Лтд. |
Моноклональные антитела человека к белку программируемой смерти 1 (pd-1) и способы лечения рака с использованием анти-pd-1-антител самостоятельно или в комбинации с другими иммунотерапевтическими средствами
|
|
JP4824389B2
(ja)
|
2005-10-28 |
2011-11-30 |
株式会社医学生物学研究所 |
エプスタイン−バールウイルス感染細胞を特異的に攻撃する細胞傷害性ｔ細胞エピトープペプチド及びその用途
|
|
EP2032719A2
(en)
|
2006-06-02 |
2009-03-11 |
GlaxoSmithKline Biologicals S.A. |
Method for identifying whether a patient will be responder or not to immunotherapy
|
|
ZA200900379B
(en)
|
2006-07-21 |
2010-08-25 |
Univ California |
Human endogenous retrovirus polypeptide compositions and methods of use thereof
|
|
US9045556B2
(en)
|
2007-02-07 |
2015-06-02 |
Nec Corporation |
Therapeutic agent for cancer
|
|
EP2134358A1
(en)
|
2007-03-19 |
2009-12-23 |
Globeimmune, Inc. |
Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer
|
|
ES2776406T3
(es)
|
2007-07-12 |
2020-07-30 |
Gitr Inc |
Terapias de combinación que emplean moléculas de enlazamiento a GITR
|
|
EP2071334A1
(en)
|
2007-12-14 |
2009-06-17 |
Transmedi SA |
Compositions and methods of detecting TIABS
|
|
DE102008010954A1
(de)
|
2008-02-25 |
2009-08-27 |
Cichon, Günter, Prof.Dr. |
DNA-Vakzine zur Therapie und Prophylaxe von Gebärmutterhalskrebs und seinen prämalignen Vorstufen
|
|
EP2105511A1
(en)
|
2008-03-28 |
2009-09-30 |
Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. |
Medicament compositions and substances for treatment and identifying adenocarcinoma of the lung
|
|
EP2331680B1
(en)
|
2008-09-22 |
2017-05-03 |
Baylor College Of Medicine |
Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
|
|
CN101885778B
(zh)
|
2009-05-13 |
2013-10-16 |
中国疾病预防控制中心病毒病预防控制所 |
Hpv16型l2n120e7e6融合蛋白、基因、制备方法及用途
|
|
JP5946770B2
(ja)
|
2009-12-10 |
2016-07-06 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
オリゴペプチドを含む医薬組成物
|
|
US9023802B2
(en)
|
2009-12-14 |
2015-05-05 |
Immatics Biotechnologies Gmbh |
HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
|
|
TW201136602A
(en)
|
2010-01-22 |
2011-11-01 |
Baylor Res Inst |
Dendritic cell vaccines
|
|
GB201006360D0
(en)
|
2010-04-16 |
2010-06-02 |
Immatics Biotechnologies Gmbh |
Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
|
|
BR112012029066A2
(pt)
|
2010-05-14 |
2020-09-01 |
The General Hospital Corporation |
composições e processos de identificação de neoantígenos específicos de tumor.
|
|
WO2011146862A1
(en)
|
2010-05-21 |
2011-11-24 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing selective apoptosis
|
|
WO2011153009A1
(en)
|
2010-06-02 |
2011-12-08 |
Abraxis Bioscience, Llc |
Methods of treating bladder cancer
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
GB2506760B
(en)
|
2011-01-14 |
2015-07-22 |
Genefirst Ltd |
Allele specific primers for EGFR exon 21 specific mutations
|
|
EP2478915A1
(en)
|
2011-01-24 |
2012-07-25 |
Genticel |
CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses
|
|
US8999937B2
(en)
|
2011-02-28 |
2015-04-07 |
Indiana University Research And Technology Corporation |
Glucocorticoid induced leucine zipper mimetics as therapeutic agents in multiple sclerosis
|
|
WO2012159643A1
(en)
|
2011-05-24 |
2012-11-29 |
Biontech Ag |
Individualized vaccines for cancer
|
|
HRP20211595T1
(hr)
|
2011-05-24 |
2022-01-21 |
BioNTech SE |
Individualizirana cjepiva protiv raka
|
|
HK1199066A1
(en)
|
2011-08-18 |
2015-06-19 |
Nestec S.A. |
Compositions and methods for detecting allelic variants
|
|
ES2834070T3
(es)
|
2011-09-15 |
2021-06-16 |
Us Health |
Receptores de células T que reconocen MAGE restringido por HLA-A1 o HLA-Cw7
|
|
WO2013086464A1
(en)
|
2011-12-07 |
2013-06-13 |
The Broad Institute, Inc. |
Markers associated with chronic lymphocytic leukemia prognosis and progression
|
|
US20130210014A1
(en)
|
2012-02-10 |
2013-08-15 |
Jeff Sharman |
Method for determining the prognosis and therapeutic response in chronic lymphocytic leukemia (cll) patients
|
|
US20160130641A1
(en)
|
2012-02-15 |
2016-05-12 |
Janssen Diagnostics, Llc |
Highly sensitive method for detecting low frequency mutations
|
|
AU2013243948A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins associated with human disease
|
|
SG10201609210SA
(en)
|
2012-05-03 |
2016-12-29 |
Hutchinson Fred Cancer Res |
Enhanced affinity t cell receptors and methods for making the same
|
|
CN113967253A
(zh)
|
2012-05-15 |
2022-01-25 |
百时美施贵宝公司 |
通过破坏pd-1/pd-l1信号传输的免疫治疗
|
|
KR102437522B1
(ko)
|
2012-05-25 |
2022-08-26 |
셀렉티스 |
면역요법을 위한 동종이형 및 면역억제제 저항성인 ｔ 세포의 조작 방법
|
|
CA2879024A1
(en)
|
2012-07-12 |
2014-01-16 |
Persimmune, Inc. |
Personalized cancer vaccines and adoptive immune cell therapies
|
|
CN104507537A
(zh)
|
2012-07-13 |
2015-04-08 |
宾夕法尼亚大学董事会 |
用于调节car t细胞的组合物和方法
|
|
AU2013295652B2
(en)
|
2012-07-27 |
2018-02-08 |
The Board Of Trustees Of The University Of Illinois |
Engineering T-cell receptors
|
|
WO2014056986A1
(en)
|
2012-10-11 |
2014-04-17 |
Universitat De Barcelona |
Method to predict the clinical evolution of a patient suffering of chronic lymphocytic leukemia (cll)
|
|
PT2961831T
(pt)
|
2013-02-26 |
2020-10-12 |
Memorial Sloan Kettering Cancer Center |
Composições e métodos para imunoterapêutica
|
|
US10176294B2
(en)
|
2013-03-15 |
2019-01-08 |
The Broad Institute, Inc. |
Accurate typing of HLA through exome sequencing
|
|
WO2014172606A1
(en)
|
2013-04-19 |
2014-10-23 |
The Brigham And Women's Hospital, Inc. |
Methods for modulating immune responses during chronic immune conditions by targeting metallothioneins
|
|
MX2015015638A
(es)
|
2013-05-13 |
2016-10-28 |
Cellectis |
Metodos para diseñar celulas t altamente activas para inmunoterapia.
|
|
WO2014191128A1
(en)
|
2013-05-29 |
2014-12-04 |
Cellectis |
Methods for engineering t cells for immunotherapy by using rna-guided cas nuclease system
|
|
EP3004877A4
(en)
|
2013-06-06 |
2017-04-19 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for identification, assessment prevention, and treatment of cancer using pd-l1 isoforms
|
|
US20160310584A1
(en)
|
2013-12-06 |
2016-10-27 |
The Broad Institute Inc. |
Formulations for neoplasia vaccines
|
|
EP3082853A2
(en)
|
2013-12-20 |
2016-10-26 |
The Broad Institute, Inc. |
Combination therapy with neoantigen vaccine
|
|
BR112016016525A2
(pt)
|
2014-01-17 |
2017-08-08 |
Dbv Tech |
Método para indução de células treg (ctla-4+, cd4+, cd25+) foxp3+ e/ou células treg lap+ em um indivíduo, método para melhorar uma condição em um indivíduo, e método para a produção de células treg (ctla-4+, cd4+, cd25+) foxp3+ e/ou células treg lap+
|
|
EP3110971B1
(en)
|
2014-02-27 |
2019-05-08 |
The Broad Institute Inc. |
T cell balance gene expression and methods of use thereof
|
|
US20160252511A1
(en)
|
2014-03-14 |
2016-09-01 |
Brian J. Czemiecki |
Methods for monitoring cd4+ t-helper type 1 response in cancer and immune restoration
|
|
US20170261508A1
(en)
|
2014-03-14 |
2017-09-14 |
The Trustees Of The University Of Pennsylvania |
Methods for monitoring cd4+ t-helper type 1 response in cancer and immune restoration
|
|
DK3152569T3
(da)
|
2014-06-05 |
2020-08-17 |
Aimm Therapeutics Bv |
Midler og fremgangsmåder til bestemmelse af t-cellegenkendelse
|
|
US20170204140A1
(en)
|
2014-07-23 |
2017-07-20 |
Deakin University |
Antagonistic peptides
|
|
RS59710B1
(sr)
|
2014-08-07 |
2020-01-31 |
Pharmassist Ltd |
Metod određivanja mutacionog statusa pik3ca u uzorku
|
|
MX2017002081A
(es)
*
|
2014-08-15 |
2017-05-23 |
Genexine Inc |
Metodo para tratar cancer de cuello uterino.
|
|
HUE040440T2
(hu)
|
2014-11-04 |
2019-03-28 |
Janssen Vaccines & Prevention Bv |
Terápiás HPV16-oltóanyagok
|
|
US10975442B2
(en)
|
2014-12-19 |
2021-04-13 |
Massachusetts Institute Of Technology |
Molecular biomarkers for cancer immunotherapy
|
|
CA2974956A1
(en)
*
|
2015-01-29 |
2016-08-04 |
The Trustees Of The University Of Pennsylvania |
Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy
|
|
EP3265562A4
(en)
|
2015-03-05 |
2018-12-19 |
TrovaGene, Inc. |
Early assessment of mechanism of action and efficacy of anti-cancer therapies using molecular markers in bodily fluids
|
|
EP3267969A1
(en)
|
2015-03-09 |
2018-01-17 |
King's College London |
Combination therapy with rar alpha agonists for enhancing th1 response
|
|
EP3075389A1
(en)
|
2015-03-31 |
2016-10-05 |
Technische Universität München |
T cell receptors and peptides derived by mutations for the treatment of cancer
|
|
US20190099475A1
(en)
|
2015-04-08 |
2019-04-04 |
Nantomics, Llc |
Cancer neoepitopes
|
|
TW202523682A
(zh)
|
2015-05-20 |
2025-06-16 |
美商博德研究所有限公司 |
共有之gata3相關之腫瘤特異性新抗原
|
|
CN107709351A
(zh)
|
2015-06-17 |
2018-02-16 |
株式会社医学生物学研究所 |
细胞毒性t细胞表位肽及其用途
|
|
WO2017004153A1
(en)
|
2015-06-29 |
2017-01-05 |
The Broad Institute Inc. |
Tumor and microenvironment gene expression, compositions of matter and methods of use thereof
|
|
WO2017011710A2
(en)
|
2015-07-14 |
2017-01-19 |
Whitehead Institute For Biomedical Research |
Chromosome neighborhood structures and methods relating thereto
|
|
US12241053B2
(en)
|
2015-10-09 |
2025-03-04 |
The Brigham And Women's Hospital, Inc. |
Modulation of novel immune checkpoint targets
|
|
EP3368687B1
(en)
|
2015-10-27 |
2021-09-29 |
The Broad Institute, Inc. |
Compositions and methods for targeting cancer-specific sequence variations
|
|
EP3708587B1
(en)
|
2015-11-27 |
2024-05-22 |
Cartherics Pty. Ltd. |
Genetically modified cells and uses thereof
|
|
CA3014252A1
(en)
|
2016-02-12 |
2017-08-17 |
Nantomics, Llc |
High-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies
|
|
CN105693828A
(zh)
|
2016-02-17 |
2016-06-22 |
深圳市中美康士生物科技有限公司 |
一种新的eb病毒ebna1表位肽及其在ebv相关疾病的诊断、治疗和预防中的用途
|
|
GB201603568D0
(en)
|
2016-03-01 |
2016-04-13 |
Immatics Biotechnologies Gmbh |
Efficient treatment options including peptides and combination of peptide and cell based medicaments for use in immunotherapy against urinary bladder cancer
|
|
FI3436048T3
(fi)
|
2016-03-31 |
2025-09-15 |
Biontech Us Inc |
Neoantigeeneja ja niiden käyttömenetelmiä
|
|
US11377637B2
(en)
|
2016-04-15 |
2022-07-05 |
Memorial Sloan Kettering Cancer Center |
Transgenic T cell and chimeric antigen receptor T cell compositions and related methods
|
|
EP3446119A1
(en)
|
2016-04-18 |
2019-02-27 |
The Broad Institute Inc. |
Improved hla epitope prediction
|
|
WO2018037416A1
(en)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating autoimmune diseases
|
|
BR112019008481A2
(pt)
*
|
2016-10-26 |
2020-03-03 |
Curevac Ag |
Vacinas de mrna de nanopartículas lipídicas
|
|
WO2018140391A1
(en)
|
2017-01-24 |
2018-08-02 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
|
WO2020000587A1
(zh)
|
2018-06-26 |
2020-01-02 |
龚浩 |
一种方便清洁的灭虫灯
|